News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
215,195 Results
Type
Article (10555)
Company Profile (30)
Press Release (204609)
Multimedia
Podcasts (29)
Webinars (4)
Section
Business (65380)
Career Advice (308)
Deals (11288)
Drug Delivery (49)
Drug Development (32779)
Employer Resources (21)
FDA (5615)
Job Trends (5072)
News (104594)
Policy (8226)
Tag
2025 Best Places to Work (3)
2026 Best Places to Work (4)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 NextGen (1)
2027 Pharm Country Digital (1)
40 Under 40 (1)
Academia (651)
Accelerated approval (37)
ADA (36)
Adcomms (11)
Allergies (116)
Alliances (8645)
ALS (103)
Alzheimer's disease (735)
Antibody-drug conjugate (ADC) (280)
Approvals (6197)
Artificial intelligence (220)
ASCO (188)
Autoimmune disease (216)
Automation (12)
Bankruptcy (76)
Belgium (15)
Best Places to Work (4423)
BIO (16)
Biologics (44)
BIOSECURE Act (5)
Biosimilars (124)
BioSpace Insights (19)
Biotechnology (20)
Bispecific (26)
Bladder cancer (164)
Brain cancer (45)
Breast cancer (459)
Cancer (3555)
Cardiovascular disease (320)
Career advice (286)
Career pathing (10)
CAR-T (146)
CDC (16)
CDMO (42)
Celiac Disease (7)
Cell therapy (447)
Cervical cancer (34)
Clinical research (32046)
Collaboration (647)
Commercialization (29)
Compensation (557)
Complete response letters (37)
COVID-19 (1032)
CRISPR (43)
CRO (1)
C-suite (275)
Cystic fibrosis (65)
Data (6271)
Decentralized trials (1)
Denatured (3)
Depression (109)
Dermatology (115)
Diabetes (392)
Diagnostics (1977)
Digital health (24)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (114)
Drug pricing (49)
Drug shortages (7)
Duchenne muscular dystrophy (140)
Earnings (43846)
Editorial (20)
Employer branding (4)
Employer resources (19)
ESMO (276)
Events (41148)
Executive appointments (241)
Eye disease (15)
FDA (7934)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (13)
Frontotemporal dementia (18)
Funding (542)
Gene editing (103)
Generative AI (20)
Gene therapy (359)
GLP-1 (569)
Government (1347)
Grass and pollen (4)
Guidances (356)
Healthcare (6050)
Hematology (136)
HIV (67)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (8)
IgA nephropathy (78)
Immunology and inflammation (169)
Immuno-oncology (68)
Indications (154)
Infectious disease (1177)
Inflammatory bowel disease (125)
Inflation Reduction Act (2)
Influenza (45)
Intellectual property (147)
Interviews (44)
IPO (7096)
IRA (8)
Job creations (839)
Job search strategy (238)
JPM (18)
Kidney cancer (13)
Kidney disease (97)
Labor market (42)
Layoffs (178)
Leadership (12)
Legal (1316)
Licensing (36)
Liver cancer (38)
Longevity (12)
Lung cancer (550)
Lung diease (15)
Lymphoma (321)
Machine learning (12)
Management (4)
Manufacturing (358)
Marketing (20)
MASH (126)
Medical affairs (3)
Medical device (4400)
Medtech (4499)
Melanoma (48)
Mergers & acquisitions (4753)
Metabolic disorders (955)
Middle East (1)
mRNA (88)
Multiple sclerosis (141)
Multispecific (1)
NASH (4)
Netherlands (16)
Neurodegenerative disease (214)
Neuropsychiatric disorders (60)
Neuroscience (1656)
NextGen: Class of 2026 (1721)
Non-profit (1181)
Now hiring (19)
Obesity (431)
Opinion (64)
Ovarian cancer (144)
Pain (131)
Pancreatic cancer (221)
Parkinson's disease (207)
Partnered (10)
Patents (325)
Patient advocacy (3)
Patient recruitment (391)
Patient selection (55)
Peanut (39)
People (9679)
Peptides (19)
Pharmaceutical (6)
Pharmacy benefit managers (7)
Phase 1 (8680)
Phase 2 (14467)
Phase 3 (11969)
Pipeline (7978)
Policy (75)
Postmarket research (1080)
Preclinical (2723)
Press Release (8)
Prostate cancer (150)
Psychedelics (57)
Radioligand (2)
Radiopharmaceuticals (122)
Rare diseases (668)
Real estate (1134)
Recruiting (8)
Regenerative medicine (15)
Regulatory (8464)
Reports (33)
Research institute (598)
Resumes & cover letters (49)
Rett syndrome (34)
RNA editing (13)
RSV (39)
Schizophrenia (117)
Series A (76)
Series B (59)
Service/supplier (1)
Sickle cell disease (90)
Special edition (11)
Spinal muscular atrophy (105)
Sponsored (13)
Startups (714)
State (1)
Stem cells (3)
Stomach cancer (8)
Substance use disorders (9)
Supply chain (34)
Switzerland (16)
Tariffs (25)
The Weekly (26)
Vaccines (487)
Venture capital (42)
Weight loss (281)
Wet AMD (4)
Women's health (76)
Women in leadership (1)
Worklife (9)
Date
Today (22)
Last 7 days (279)
Last 30 days (2015)
Last 365 days (13492)
2026 (11939)
2025 (12746)
2024 (13940)
2023 (14203)
2022 (18660)
2021 (19056)
2020 (17261)
2019 (14629)
2018 (10186)
2017 (9131)
2016 (8125)
2015 (10418)
2014 (7280)
2013 (5358)
2012 (5797)
2011 (5900)
2010 (5463)
Location
Africa (175)
Alabama (26)
Alaska (1)
Arizona (139)
Arkansas (2)
Asia (12979)
Australia (2006)
California (6849)
Canada (1756)
China (837)
Colorado (297)
Connecticut (327)
Delaware (253)
Europe (30699)
Florida (923)
Georgia (235)
Hawaii (2)
Idaho (13)
Illinois (512)
India (61)
Indiana (376)
Iowa (10)
Japan (364)
Kansas (56)
Kentucky (15)
Louisiana (32)
Maine (39)
Maryland (796)
Massachusetts (4960)
Michigan (123)
Minnesota (341)
Mississippi (1)
Missouri (62)
Montana (8)
Nebraska (4)
Nevada (76)
New Hampshire (32)
New Jersey (2346)
New Mexico (4)
New York (1816)
North Carolina (858)
North Dakota (1)
Northern California (3689)
Ohio (158)
Oklahoma (1)
Oregon (9)
Pennsylvania (1344)
Puerto Rico (11)
Rhode Island (11)
South America (287)
South Carolina (23)
Southern California (2735)
Tennessee (68)
Texas (1020)
United States (24115)
Utah (181)
Virginia (117)
Washington D.C. (20)
Washington State (472)
West Virginia (2)
Wisconsin (35)
Wyoming (1)
215,195 Results for "12".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Novartis faces $1.9B hit from Avidity fail but maintains confidence in $12B buy
Novartis remains “very happy” with its $12 billion acquisition of Avidity Biosciences, despite a Phase 3 disappointment for the antibody-oligonucleotide conjugate del-desiran.
October 27, 2026
·
4 min read
·
Tristan Manalac
Pancreatic cancer
EMSO 2026: Incyte a ‘firm contender’ in G12D pancreatic cancer race as early candidate shines
In a Phase 1 study, treatment with Incyte’s KRAS G12D inhibitor in combination with standard-of-care chemotherapy elicited an 89% confirmed objective response rate in patients with a type of pancreatic ductal adenocarcinoma, leading analysts to draw comparisons with Revolution Medicines’ zoldonrasib.
October 27, 2026
·
3 min read
·
Michael Gibney
Press Releases
Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study
November 3, 2026
·
4 min read
Career Advice
The top 12 companies hiring in biopharma now
Average jobs live on
BioSpace
increased year over year in October, a good sign for those eyeing a new position. If that’s you, check out the list of which companies are most actively looking to hire.
November 5, 2026
·
1 min read
·
Angela Gabriel
Press Releases
GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12
November 3, 2026
·
6 min read
Press Releases
Savara Announces New Employment Inducement Grant - November 12, 2026
November 13, 2026
·
2 min read
Press Releases
Cosmos Health’s U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks
October 29, 2026
·
7 min read
Press Releases
Vir Biotechnology Announces Proposed Public Offering - November 12, 2026
November 13, 2026
·
4 min read
Press Releases
Biomea Fusion to Participate in Upcoming Investor Conferences - November 12, 2026
November 12, 2026
·
1 min read
Press Releases
Cellectis to Report Third Quarter Financial Results on November 12, 2026
November 10, 2026
·
1 min read
1 of 21,520
Next